Persistent or Transient Human β-Cell Dysfunction Induced by Metabolic Stress Associates with Specific Signatures and Shared Gene Expression of Type 2 Diabetes
Pancreatic β-cell failure is key to type 2 diabetes (T2D) onset and progression. We assessed whether human β-cell dysfunction induced by metabolic stress is reversible, evaluated the molecular pathways underlying persistent or transient damage, and explored the relationships with T2D islet traits. Twenty-six human islet preparations were exposed to several lipo- and/or glucotoxicity conditions, some of which impaired insulin release depending on stressor type, concentration and combination. Interestingly, reversal of dysfunction occurred after wash out for some, but not for all, of the lipoglucotoxic insults. Islet transcriptomes assessed by RNA-sequencing and eQTL analysis identified specific pathways underlying β-cell failure and recovery. Notably, comparison of a large number of human T2D islet transcriptomes with those of persistent or reversible β-cell lipoglucotoxicity showed shared gene expression signatures. The identification of mechanisms associated with human β-cell dysfunction and recovery, and their overlap with T2D islet traits provide novel insights into T2D pathogenesis and should foster the development of improved β-cell targeted therapeutic strategies.
Marselli, Lorella and Piron, Anthony and Suleiman, Mara and Colli, Maikel and Khamis, Amna and Rutter, Guy and Bugliani, Marco and Giusti, Laura and Ronci, Maurizio and Ibberson, Mark and Turatsinze, Jean-Valry and Boggi, Ugo and De Simone, Paolo and De Tata, Vincenzo and Lopes, Miguel and Nasteska, Daniela and De Luca, Carmela and Singh, Pratibha and Campani, Daniela and Shulte, Anke and Solimena, Michele and Hecht, Peter and Rady, Brian and Bakaj, Ivon and Pocai, Alessandro and Norquay, Lisa and Thorens, Bernard and Canouil, Mickael and Frogues, Philippe and Eizirik, Decio and Cnop, Miriam and Marchetti, Piero, Persistent or Transient Human β-Cell Dysfunction Induced by Metabolic Stress Associates with Specific Signatures and Shared Gene Expression of Type 2 Diabetes. Available at SSRN: https://ssrn.com/abstract=3565026 or http://dx.doi.org/10.2139/ssrn.3565026
This version of the paper has not been formally peer reviewed.